Envoy Medical (COCH) Return on Capital Employed (2021 - 2026)
Envoy Medical recorded quarterly Return on Capital Employed of 331.31% in Q1 2026, down 147.49% quarter-over-quarter from 697.57% in Q4 2025, and up 24733.0% year-over-year from N/an in Q1 2025.
Envoy Medical's Return on Capital Employed history runs 6 years deep, the most recent figure standing at 331.31% for Q1 2026.
- In Q1 2026, Return on Capital Employed rose 24733.0% year-over-year to 331.31%; the TTM figure through Mar 2026 stood at 331.31% (up 24733.0% YoY), while the FY2025 annual figure was 1470.94%, up 228463.0% from the prior year.
- Return on Capital Employed came in at 331.31% for Q1 2026 at Envoy Medical, down from 697.57% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 4414.68% in Q2 2024 to a low of 38921.9% in Q3 2025.
- A 5-year average of 2117.88% and a median of 63.6% in 2023 frame the typical range for Return on Capital Employed.
- Across the five-year window, Return on Capital Employed surged 445053 bps in 2024 and plunged 4105011 bps in 2025, its largest moves.
- Envoy Medical's Return on Capital Employed stood at 3.34% in 2022, then sank by 7281 bps to 246.17% in 2023, then slumped by 167 bps to 657.35% in 2024, then jumped by 206 bps to 697.57% in 2025, then plunged by 147 bps to 331.31% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 331.31%, 697.57%, and 38921.9% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 7.62% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 11.57% |
| 10 | Envoy Medical | 48.11 Mn | 22.86 Mn | -274,000.00 | -331.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -331.31% |
| Dec 31, 2025 | 697.57% |
| Sep 30, 2025 | -38,921.90% |
| Jun 30, 2025 | -919.39% |
| Mar 31, 2025 | -578.64% |
| Dec 31, 2024 | -657.35% |
| Sep 30, 2024 | 2,128.20% |
| Jun 30, 2024 | 4,414.68% |
| Mar 31, 2024 | -1,411.53% |
| Dec 31, 2023 | -246.17% |
| Sep 30, 2023 | -71.15% |
| Jun 30, 2023 | -35.85% |
| Mar 31, 2023 | -63.60% |
| Dec 31, 2022 | -3.34% |
| Sep 30, 2022 | -1.22% |
| Jun 30, 2022 | -1.50% |
| Mar 31, 2022 | -1.54% |
| Dec 31, 2021 | -1.41% |